WHO ICTRP trial
Efficacy and safety of the fixed combination Timolol 0,5%/Travoprost 0,004%…
ACTRN12612000247875 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12612000247875 |
|---|---|
| Public title | Efficacy and safety of the fixed combination Timolol 0,5%/Travoprost 0,004% compared the concomitant administration to the single components. |
| Scientific title | Effect of the fixed versus unfixed combination of timolol and travoprost on intraocular pressure in 40 Caucasian patients with primary open angle glaucoma or ocular hypertension in 6 months follow up period. |
| Primary sponsor | Luigi Mazzeo,Md |
| Secondary sponsors | Elena Pacella,MD |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Italy |
| Conditions | Primary open angle glaucoma;Ocular hypertension; Primary open angle glaucoma Ocular hypertension;Eye - Diseases / disorders of the eye |
| Interventions | Use of timolol and travoprost in treatment of primary open angle glaucoma. Arm 1-Timolol 0,5% twice daily was instilled for 30 days in 80 eyes Arm 2- Timolol 0,5% twice daily and travoprost 0,004% once a day were instilled for 30 days. Arm… |
| Registration date | Feb 28, 2012 |
| Target size | 40 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: